243 related articles for article (PubMed ID: 3051946)
1. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
[TBL] [Abstract][Full Text] [Related]
2. [Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects].
Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
Hinyokika Kiyo; 1988 May; 34(5):905-17. PubMed ID: 3051945
[TBL] [Abstract][Full Text] [Related]
3. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
4. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
5. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
6. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
[TBL] [Abstract][Full Text] [Related]
7. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
8. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
Nicar MJ; Hsu MC; Fetner C
Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069
[TBL] [Abstract][Full Text] [Related]
9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
10. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
Hannak D; Burczyk U; Bartelt U; Kattermann R
Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
Pak CY; Koenig K; Khan R; Haynes S; Padalino P
J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
[TBL] [Abstract][Full Text] [Related]
12. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
Penniston KL; Steele TH; Nakada SY
Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
14. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
Normand M; Cayotte JL; Houillier P; Peuchant A; Paillard M
Nephrologie; 1993; 14(6):283-5. PubMed ID: 8145886
[TBL] [Abstract][Full Text] [Related]
15. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
Butz M
Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of calcium nephrolithiasis with potassium citrate.
Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
[TBL] [Abstract][Full Text] [Related]
17. [Calcium and citrate excretion by patients with calculi and healthy probands during induced acidosis].
Bothor C; Berg W; Donner M; Pirlich W
Urologe A; 1989 Mar; 28(2):112-5. PubMed ID: 2718293
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies of citrate therapy on urolithiasis--estimations of urinary citrate excretion in patients with urolithiasis and the results of treatment with sodium-potassium citrate].
Yasukawa S
Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):620-8. PubMed ID: 3226014
[No Abstract] [Full Text] [Related]
20. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
